Pimavanserin
Selective 5-HT2A inverse agonist for PD psychosis — efficacy, mortality-warning history and ongoing trials.
State of the art
No update yet for Pimavanserin. An update is a standalone state-of-the-art for the topic — what someone with Parkinson's needs to know about where this approach stands today.
No reader summaries on this topic yet.